- Filed
- May 15, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 15, 2025 | 35.92M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2025 | 30.9M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 30.17M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $24.29M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $23.97M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $5.44M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $4.96M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $9.68M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $12.1M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $77.8M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $68.77M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $119.37M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $109.39M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $47.54M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $41.34M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $98.98M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $88.05M |
| Eps Diluted | Q1 2025 · Mar 31, 2025 | −$0.14 |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.07 |
| Eps Basic | Q1 2025 · Mar 31, 2025 | −$0.14 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.07 |
| Capex | Q1 2025 · Mar 31, 2024 | $385K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$3.61M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | −$14.21M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | −$12.57M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$2.21M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | $1.33M |
| Gross Profit restated | Q1 2025 · Mar 31, 2024 | $10.03M |